We thank our partners and sponsors for the Biomedica on the Move 2021:
The Interface Entreprises of the University of Liege is focused on open innovation and technology transfer at local and international levels, in several, often cross-disciplinary, fields (life sciences, engineering, social sciences, sustainable developments).
The Euregional Networking Organisations:
The collaborating projects and partners:
Wearables, Implantables, ingestibles, invisibles: sensor innovations assisting our health
Smart watches, wearables and other sensors are increasingly adding value to (out)patient monitoring and their deployment has been particularly successful for cardiovascular disease monitoring. For neurological, pulmonary, orthopedic, nephrological, ophtalmological applications, different form factors are needed and examples will be shown. For very long-term monitoring towards prevention or early disease interception, alternatives are needed to ensure patient/user compliance - and we call these devices ‘invisibles’. The comprehensive data from these new devices will enable the creation of human digital twin AI models for personalized risk factor assessment, early diagnostics, and feedback.
By Chris Van Hoof,
Vice President imec, Connected Health Solutions
General Manager One Planet Research Center
+32 475 68 01 89 - firstname.lastname@example.org
The pitching SMEs:
CERHUM (Human Ceramics) Is specialized in 3D printing of ceramic-based medical devices. Our business includes two main activities:
Production of custom bone implants: We have developed a custom bone graft solution called MyBone. In order to ensure a better biocompatibility and bone regeneration with this product, we use the same material that constitutes bone mineral part “hydroxyapatite”.
CDMO for the 3D printing of ceramics: our know-how and our experience in ceramic 3D printing enable us to assist our customers in the development and production of ceramics medical device.
By BOUAKAZ Islam, Ph.D., Researcher and Project leader at CERHUM
ITA GmbH is the partner of the industry in the field of research & development with the main focus on man-made fibre technology, textile machinery, fibre composites, biohybrid & medical textiles as well as for technology transfer to other industrial sectors.
With our know-how, we offer industry comprehensive problem solutions along the textile chain and provide support for the transfer.
By Dipl.-Ing. Ly Dang Khoa Do (Mr.), Project Manager
Demcon provides solutions for a wide range of OEM customers in healthcare, and in addition we are developing our own product line. Both for the own product line as for questions from OEM customers there is a trend from hospital to home care, from standing models to wearable solutions. We have realised awesome innovations for diagnosis and treatment in this area, and I am looking forward to take you with me on our journey and which lessons we have learned. In this pitch I will tell you more about MedRings. This is an Intelligent drug delivery and diagnostics tool for women.The heart of this device is an electromechanical system. The vaginal mucosa has proven to be an excellent place for diagnostics, due to the close vicinity of dense vascularization. First pilots show the electromechanical nature of the product makes it ‘smart’ and provides flexibility in dosage, schedule and timing. The device can be wirelessly adjusted and controlled.
By Benjamin Jurg, Business developer Healthcare Demcon
+31(0)6 12543720, email@example.com
Nano-fiber technology has the potential to revolutionize the medical device industry. Nano-fibers mimic the natural environment of cells in the human body in architecture and size-scale. Therefore, implants based on nano-fibers are very well received by the body and unwanted side-effects of implantation, such as inflammation or rejection, are minimized. Instead, the nano-fibers dissolve in time and get replaced by natural tissue. This way, the implant helps the human body to heal itself.
By Judith Heikoop, Ph.D., CEO
iol Strategic Design is a study office in industrial design with over 22 years of experience in designing medical devices. We guide customers from the innovation quest to the development of functional prototypes.
Our team of 7 peoples aims to materialize the ideas of its customers. We place the user at the center of the development to reach a targeted design, good ergonomics of use and a product technically feasible. Having our own prototyping lab allows us to offer our client a high responsiveness in the validation of the project throughout the development. Thanks to our experience of designing medical devices, we work in line with the relevant standards.
By Laura Hong, Designer
+32 488 68 31 59, firstname.lastname@example.org
TRusted AI Labs (TRAIL) aims to create a mezzanine structure to mobilise the research and innovation capacities of the Walloon and Brussels regions in the service of their socio-economic development in the field of Artificial Intelligence in coherence with the regional policies conducted in this field.
By Prof. Benoît Macq, Coordinator
Achilles supports and co-develop companies who wants to develop wearables and healthcare products with a human-centric focus. We manage and take care of the overall product development that covers product system design, digital design, electronics, mechanical engineering and usability design.
Some of our co-developed wearables already on the market are the Nyxoah sleep apneu implant device and a long term EEG monitoring system from Uneeg medical. We developed a smart glass for healthcare applications with Iristick and we collaborate with Moonbird to develop a stress relaxation device.
We are happy to share our expertise to develop your idea or technology and create a market ready product/service.
By Tim Ruytjens, Senior manager product design
+32 473 30 32 30, email@example.com
We believe that healthcare will shift from a centralised to a decentralised system where patient follow-up outside of the hospital wall will be essential. At Byteflies, we want to play in important role in this shift which is accelerated by the current COVID crisis. We are currently offering our CovidCare@Home solution to hospitals that need help in the acute crisis.
By Hans Danneels, Co-founder & CEO
+32 460 94 83 49, firstname.lastname@example.org
"Up to 1 billion people, nearly one in six of the world’s population, suffer from neurological disorders" (news.un.org, 2007) At epihunter we believe digital technologies can have a massive impact on the lives of people with such condition. We are a Belgian company focused on creating digital solutions that make the condition matter less in daily life while generating real world data for better treatments. In less than 3 years, we have grown a disruptive vision into a first CE class I product for absence epilepsy on the market in Europe and Australia, supported by both b2c and b2b business models. Our first product combines an EEG wearable with smartphone technology and machine learning algorithms to detect, signal, log and video-record silent, difficult to notice epileptic absence seizures in real world and real time. In addition additional smartphone apps provide for automated seizure diaries and a web portal is used by healthcare professionals for better diagnosis and follow-up.
By Tim Buckinx, Founder & CEO